TY - JOUR
T1 - Muscle Strength and Physical Performance Improve Fracture Risk Prediction Beyond Garvan and FRAX
T2 - The Osteoporotic Fractures in Men (MrOS) Study
AU - Alajlouni, Dima
AU - Tran, Thach
AU - Bliuc, Dana
AU - Blank, Robert D.
AU - Cawthon, Peggy M.
AU - Orwoll, Eric S.
AU - Center, Jacqueline R.
N1 - Funding Information:
The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The following institutes provide support: the National Institute on Aging (NIA), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Center for Advancing Translational Sciences (NCATS), and NIH Roadmap for Medical Research under the following grant numbers: U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, and UL1 TR000128. JRC is the recipient of an Australian Medical Research Futures Fund (MRFF) grant 1137462. DA is the recipient of an Australian Government Research Training Program (RTP) Scholarship. The funders of this study had no role in the study design, data collection, analysis, or interpretation, writing the manuscript, or the decision to submit the manuscript for publication. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Funding Information:
The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The following institutes provide support: the National Institute on Aging (NIA), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Center for Advancing Translational Sciences (NCATS), and NIH Roadmap for Medical Research under the following grant numbers: U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, and UL1 TR000128. JRC is the recipient of an Australian Medical Research Futures Fund (MRFF) grant 1137462. DA is the recipient of an Australian Government Research Training Program (RTP) Scholarship. The funders of this study had no role in the study design, data collection, analysis, or interpretation, writing the manuscript, or the decision to submit the manuscript for publication. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. Authorsʼ roles: Conceptualization and methodology: DA, JRC, DB, TT, and RDB. Acquisition of data: PMC and ESO. Formal analysis: DA, DB, and TT. Interpretation of results: DA, DB, TT, JRC, and RDB. Writing the original draft: DA. Reviewing and editing: JRC, DB, TT, RDB, PMC, and ESO. Funding acquisition: PMC, ESO, and JRC. Supervision: JRC, DB, and TT.
Publisher Copyright:
© 2021 American Society for Bone and Mineral Research (ASBMR).
PY - 2022/3
Y1 - 2022/3
N2 - Muscle strength and physical performance are associated with fracture risk in men. However, it is not known whether these measurements enhance fracture prediction beyond Garvan and FRAX tools. A total of 5665 community-dwelling men, aged ≥65 years, from the Osteoporotic Fractures in Men (MrOS) Study, who had data on muscle strength (grip strength) and physical performance (gait speed and chair stand tests), were followed from 2000 to 2019 for any fracture, major osteoporotic fracture (MOF), initial hip, and any hip fracture. The contributions to different fracture outcomes were assessed using Cox's proportional hazard models. Tool-specific analysis approaches and outcome definitions were used. The added predictive values of muscle strength and physical performance beyond Garvan and FRAX were assessed using categorical net reclassification improvement (NRI) and relative importance analyses. During a median follow-up of 13 (interquartile range 7–17) years, there were 1014 fractures, 536 MOFs, 215 initial hip, and 274 any hip fractures. Grip strength and chair stand improved prediction of any fracture (NRI for grip strength 3.9% and for chair stand 3.2%) and MOF (5.2% and 6.1%). Gait speed improved prediction of initial hip (5.7%) and any hip (7.0%) fracture. Combining grip strength and the relevant performance test further improved the models (5.7%, 8.9%, 9.4%, and 7.0% for any, MOF, initial, and any hip fractures, respectively). The improvements were predominantly driven by reclassification of those with fracture to higher risk categories. Apart from age and femoral neck bone mineral density, muscle strength and performance were ranked equal to or better than the other risk factors included in fracture models, including prior fractures, falls, smoking, alcohol, and glucocorticoid use. Muscle strength and performance measurements improved fracture risk prediction in men beyond Garvan and FRAX. They were as or more important than other established risk factors. These measures should be considered for inclusion in fracture risk assessment tools.
AB - Muscle strength and physical performance are associated with fracture risk in men. However, it is not known whether these measurements enhance fracture prediction beyond Garvan and FRAX tools. A total of 5665 community-dwelling men, aged ≥65 years, from the Osteoporotic Fractures in Men (MrOS) Study, who had data on muscle strength (grip strength) and physical performance (gait speed and chair stand tests), were followed from 2000 to 2019 for any fracture, major osteoporotic fracture (MOF), initial hip, and any hip fracture. The contributions to different fracture outcomes were assessed using Cox's proportional hazard models. Tool-specific analysis approaches and outcome definitions were used. The added predictive values of muscle strength and physical performance beyond Garvan and FRAX were assessed using categorical net reclassification improvement (NRI) and relative importance analyses. During a median follow-up of 13 (interquartile range 7–17) years, there were 1014 fractures, 536 MOFs, 215 initial hip, and 274 any hip fractures. Grip strength and chair stand improved prediction of any fracture (NRI for grip strength 3.9% and for chair stand 3.2%) and MOF (5.2% and 6.1%). Gait speed improved prediction of initial hip (5.7%) and any hip (7.0%) fracture. Combining grip strength and the relevant performance test further improved the models (5.7%, 8.9%, 9.4%, and 7.0% for any, MOF, initial, and any hip fractures, respectively). The improvements were predominantly driven by reclassification of those with fracture to higher risk categories. Apart from age and femoral neck bone mineral density, muscle strength and performance were ranked equal to or better than the other risk factors included in fracture models, including prior fractures, falls, smoking, alcohol, and glucocorticoid use. Muscle strength and performance measurements improved fracture risk prediction in men beyond Garvan and FRAX. They were as or more important than other established risk factors. These measures should be considered for inclusion in fracture risk assessment tools.
KW - AGING
KW - FRACTURE RISK ASSESSMENT
KW - GENERAL POPULATION STUDIES
KW - SARCOPENIA
UR - http://www.scopus.com/inward/record.url?scp=85120775457&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120775457&partnerID=8YFLogxK
U2 - 10.1002/jbmr.4483
DO - 10.1002/jbmr.4483
M3 - Article
C2 - 34842309
AN - SCOPUS:85120775457
SN - 0884-0431
VL - 37
SP - 411
EP - 419
JO - Journal of Bone and Mineral Research
JF - Journal of Bone and Mineral Research
IS - 3
ER -